PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 21196815-7 2011 Treatment with hexachlorophene (an inhibitor of beta-catenin) reduces the proliferation of pancreatic cells despite the presence of PAUF. Hexachlorophene 15-30 catenin beta 1 Homo sapiens 48-60 30525075-1 2018 Introduction: We previously reported that transplantation of hepatic cell sheets from human bone marrow-derived mesenchymal stem cells (BM-MSCs) with hexachlorophene, a Wnt/beta-catenin signaling inhibitor, ameliorated acute liver injury. Hexachlorophene 150-165 catenin beta 1 Homo sapiens 173-185 16735606-0 2006 Hexachlorophene inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin degradation. Hexachlorophene 0-15 catenin beta 1 Homo sapiens 29-41 19091460-0 2009 Hexachlorophene suppresses beta-catenin expression by up-regulation of Siah-1 in EBV-infected B lymphoma cells. Hexachlorophene 0-15 catenin beta 1 Homo sapiens 27-39 19091460-3 2009 Conversely, results from cell-based small molecule screening studies have shown that the antibiotic hexachlorophene can down-regulate beta-catenin in colon cancer cells. Hexachlorophene 100-115 catenin beta 1 Homo sapiens 134-146 19091460-4 2009 Here we report that hexachlorophene also counteracts the elevated beta-catenin levels in EBV-infected B lymphomas. Hexachlorophene 20-35 catenin beta 1 Homo sapiens 66-78 19091460-7 2009 The hexachlorophene modulation of Siah-1 and beta-catenin is independent of p53 and results in reduced expression of cyclin-D1 and c-Myc (target genes of beta-catenin), leading to the growth arrest of B lymphoma cells. Hexachlorophene 4-19 catenin beta 1 Homo sapiens 45-57 19091460-7 2009 The hexachlorophene modulation of Siah-1 and beta-catenin is independent of p53 and results in reduced expression of cyclin-D1 and c-Myc (target genes of beta-catenin), leading to the growth arrest of B lymphoma cells. Hexachlorophene 4-19 catenin beta 1 Homo sapiens 154-166 19091460-8 2009 From these results we propose that hexachlorophene may provide a novel therapeutic strategy for EBV-infected B lymphoma cells by reducing beta-catenin levels via the restoration of Siah-1. Hexachlorophene 35-50 catenin beta 1 Homo sapiens 138-150 16735606-0 2006 Hexachlorophene inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin degradation. Hexachlorophene 0-15 catenin beta 1 Homo sapiens 77-89 16735606-3 2006 In this study, we identified hexachlorophene as an inhibitor of Wnt/beta-catenin signaling from cell-based small-molecule screening. Hexachlorophene 29-44 catenin beta 1 Homo sapiens 68-80 16735606-4 2006 Hexachlorophene antagonized CRT that was stimulated by Wnt3a-conditioned medium by promoting the degradation of beta-catenin. Hexachlorophene 0-15 catenin beta 1 Homo sapiens 112-124 16735606-6 2006 In addition, hexachlorophene represses the expression of cyclin D1, which is a known beta-catenin target gene, and inhibits the growth of colon cancer cells. Hexachlorophene 13-28 catenin beta 1 Homo sapiens 85-97 16735606-7 2006 Our findings suggest that hexachlorophene attenuates Wnt/beta-catenin signaling through the Siah-1-mediated beta-catenin degradation. Hexachlorophene 26-41 catenin beta 1 Homo sapiens 57-69 16735606-7 2006 Our findings suggest that hexachlorophene attenuates Wnt/beta-catenin signaling through the Siah-1-mediated beta-catenin degradation. Hexachlorophene 26-41 catenin beta 1 Homo sapiens 108-120